Nordic's Nycomed sale triggers Eu4bn repayments

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Nordic's Nycomed sale triggers Eu4bn repayments

Leveraged loan investors are to receive around Eu4bn in repayments from Japanese drug company Takeda’s acquisition of Swiss firm Nycomed from private equity firm Nordic Capital. Takeda is paying around Eu9.6bn for Nycomed, a figure that includes all the company’s net debt.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • European securitization issuance database
  • Daily newsletters across markets and asset classes
  • 1 weekly securitization podcast

Related articles

Gift this article